| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock, $0.00001 par value per share |
| (b) | Name of Issuer:
Veradermics, Incorporated |
| (c) | Address of Issuer's Principal Executive Offices:
470 James Street, New Haven,
CONNECTICUT
, 06513. |
Item 1 Comment:
Explanatory Note:
This Amendment No. 1 amends and supplements the Schedule 13D originally filed with the Commission on February 2, 2026 (the Original Schedule 13D) and is being filed by Longitude Capital Partners V, LLC (LCPV), Longitude Venture Partners V, L.P. (LVPV), Longitude 103.8 East Partners, LLC (L103P) and Longitude 103.8 East, L.P. (L103 and together with LCPV, LVPV and L103P, the Reporting Entities) and Patrick G. Enright, a member of the Issuer's board of directors, and Juliet Tammenoms Bakker (together, the Reporting Individuals). The Reporting Entities and the Reporting Individuals are collectively referred to as the Reporting Persons. The Reporting Persons expressly disclaim status as a group for purposes of this Schedule 13D. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached to the Original Schedule 13D as Exhibit 1. Each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person's pecuniary interest therein, other than those securities reported herein as being held directly by such Reporting Person. Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13D remain unchanged. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Statement have the meanings ascribed to them in the Original Schedule 13D. |
| Item 2. | Identity and Background |
|
| (a) | The information set forth in Item 2(a) of the Original Schedule 13D is incorporated herein by reference. |
| (b) | The information set forth in Item 2(b) of the Original Schedule 13D is incorporated herein by reference. |
| (c) | The information set forth in Item 2(c) of the Original Schedule 13D is incorporated herein by reference. |
| (d) | The information set forth in Item 2(d) of the Original Schedule 13D is incorporated herein by reference. |
| (e) | The information set forth in Item 2(e) of the Original Schedule 13D is incorporated herein by reference. |
| (f) | The information set forth in Item 2(f) of the Original Schedule 13D is incorporated herein by reference. |
| Item 3. | Source and Amount of Funds or Other Consideration |
| | The information set forth in Item 3 of the Original Schedule 13D is incorporated herein by reference. |
| Item 4. | Purpose of Transaction |
| | The information set forth in Item 4 of the Original Schedule 13D is incorporated herein by reference. |
| Item 5. | Interest in Securities of the Issuer |
| (a) | See Items 7-11 of the cover pages of this Statement and Item 2 above. Except to the extent of his, hers, or its pecuniary interest therein, each Reporting Person disclaims beneficial ownership of such shares of Common Stock, except for the shares, if any, such Reporting Person holds of record.
Longitude Capital Management Co., LLC (LCM), the investment advisor of LVPV and L103, and Seven Fleet Advisors LLC (together with its affiliates, Seven Fleet) have instituted policies and procedures that may affect the acquisition, holding and disposition of securities held by Seven Fleet. As a result of such policies and procedures, the Reporting Persons and Seven Fleet may be deemed to be members of a group within the meaning of Section 13(d)(3) of the Exchange Act.
As of the date hereof, based on information provided by or on behalf of Seven Fleet, Seven Fleet may be deemed to be the beneficial owner of 80,000 shares of Common Stock, constituting 0.2% of the number of shares of Common Stock outstanding (based on 41,184,080 shares of Common Stock outstanding, consisting of (i) 37,340,290 shares of Common Stock outstanding as of March 25, 2026, as reported by the Issuer in the Form 10-K, plus (ii) 3,843,790 shares of Common Stock sold by the Issuer on May 1, 2026, as disclosed in the Form 8-K). Notwithstanding such policies and procedures, the Reporting Persons expressly disclaim such group membership and beneficial ownership over any Common Stock that they may be deemed to beneficially own by reason of such policies and procedures. This Schedule 13D shall not be deemed an admission that the Reporting Persons are members of a group for purposes of Section 13 of the Exchange Act or for any other purpose. |
| (b) | See Items 7-11 of the cover pages of this Statement and Item 2 and Item 5(a) above. Except to the extent of his, hers, or its pecuniary interest therein, each Reporting Person disclaims beneficial ownership of such shares of Common Stock, except for the shares, if any, such Reporting Person holds of record. |
| (c) | Except as reported in this Statement, none of the Reporting Persons has effected any transactions in the Issuer's securities within the past 60 days. |
| (d) | Under certain circumstances set forth in the limited partnership agreements of LVPV and L103, the general partner and limited partners of each of LVPV and L103 may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the Issuer owned by such entity of which they are a partner. |
| (e) | Not applicable. |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
| | The information set forth in Item 6 of the Original Schedule 13D is incorporated herein by reference. |
